PMID- 10581177 OWN - NLM STAT- MEDLINE DCOM- 20000106 LR - 20131121 IS - 0006-291X (Print) IS - 0006-291X (Linking) VI - 266 IP - 1 DP - 1999 Dec 9 TI - Cyclic AMP inhibits the activity of c-Jun N-terminal kinase (JNKp46) but not JNKp55 and ERK2 in human helper T lymphocytes. PG - 129-34 AB - The cyclic AMP (cAMP) elevating agent PGE(2) and dibutyryl cyclic AMP (dBcAMP) affect T cell functions. Using human helper T cell clones, we examined effects of cAMP on c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK), which are assumed to play a role in T cell regulation. When we analyzed the effects of dBcAMP on activities of mitogen-activated protein kinase (MAPK) family members ERK2, JNKp55 and JNKp46, dBcAMP did not inhibit the activities of ERK2 and JNKp55 induced by PMA/A23187 stimulation. JNKp46 activity was, however, inhibited by dBcAMP. JNK phosphorylates c-Jun on Ser-63 and Ser-73, the result being induction of its transcriptional activity. We found that dBcAMP inhibited the phosphorylation of c-Jun Ser-63 induced by PMA/A23187 stimulation. We suggest a different mechanism of regulation of JNKp55 and JNKp46 activities and that JNKp46 is a specific c-Jun kinase by which the activity of c-Jun is regulated in T lymphocytes. CI - Copyright 1999 Academic Press. FAU - Harada, Y AU - Harada Y AD - Department of Molecular and Developmental Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. FAU - Miyatake, S AU - Miyatake S FAU - Arai, K AU - Arai K FAU - Watanabe, S AU - Watanabe S LA - eng PT - Journal Article PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Antibodies) RN - 0 (Myelin Basic Protein) RN - 0 (Proto-Oncogene Proteins c-jun) RN - 0 (Recombinant Fusion Proteins) RN - 17885-08-4 (Phosphoserine) RN - 37H9VM9WZL (Calcimycin) RN - 63X7MBT2LQ (Bucladesine) RN - E0399OZS9N (Cyclic AMP) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Antibodies/immunology MH - Bucladesine/pharmacology MH - Calcimycin/pharmacology MH - Cell Line MH - Cyclic AMP/*metabolism MH - Enzyme Activation/drug effects MH - Humans MH - JNK Mitogen-Activated Protein Kinases MH - Mitogen-Activated Protein Kinase 1/*metabolism MH - Mitogen-Activated Protein Kinases/*antagonists & inhibitors/chemistry/immunology/*metabolism MH - Molecular Weight MH - Myelin Basic Protein/metabolism MH - Phosphorylation/drug effects MH - Phosphoserine/metabolism MH - Precipitin Tests MH - Proto-Oncogene Proteins c-jun/metabolism MH - Recombinant Fusion Proteins/metabolism MH - Signal Transduction/drug effects MH - T-Lymphocytes, Helper-Inducer/drug effects/*enzymology/metabolism MH - Tetradecanoylphorbol Acetate/pharmacology EDAT- 1999/12/03 00:00 MHDA- 1999/12/03 00:01 CRDT- 1999/12/03 00:00 PHST- 1999/12/03 00:00 [pubmed] PHST- 1999/12/03 00:01 [medline] PHST- 1999/12/03 00:00 [entrez] AID - 10.1006/bbrc.1999.1783 [doi] AID - S0006291X99917837 [pii] PST - ppublish SO - Biochem Biophys Res Commun. 1999 Dec 9;266(1):129-34. doi: 10.1006/bbrc.1999.1783.